297 related articles for article (PubMed ID: 8116051)
1. HLA-DR mismatching correlates with early cardiac allograft rejection, incidence, and graft survival when high-confidence-level serological DR typing is used.
De Mattos AM; Head MA; Everett J; Hosenpud J; Hershberger R; Cobanoglu A; Ott G; Ratkovec R; Norman DJ
Transplantation; 1994 Feb; 57(4):626-30. PubMed ID: 8116051
[TBL] [Abstract][Full Text] [Related]
2. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
Herzberg GZ; Rossi AF; Courtney M; Gelb BD
J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
[TBL] [Abstract][Full Text] [Related]
3. HLA compatibility and liver transplant outcome. Improved patient survival by HLA and cross-matching.
Nikaein A; Backman L; Jennings L; Levy MF; Goldstein R; Gonwa T; Stone MJ; Klintmalm G
Transplantation; 1994 Oct; 58(7):786-92. PubMed ID: 7940711
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-2 receptor blockade in cardiac transplantation: influence of HLA-DR locus incompatibility on treatment efficacy.
Lietz K; John R; Beniaminovitz A; Burke EM; Suciu-Foca N; Mancini DM; Edwards NM; Itescu S
Transplantation; 2003 Mar; 75(6):781-7. PubMed ID: 12660501
[TBL] [Abstract][Full Text] [Related]
5. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
6. HLA-DR matching improves survival after heart transplantation: is it time to change allocation policies?
Kaczmarek I; Deutsch MA; Rohrer ME; Beiras-Fernandez A; Groetzner J; Daebritz S; Schmoeckel M; Spannagl M; Meiser B; Reichart B
J Heart Lung Transplant; 2006 Sep; 25(9):1057-62. PubMed ID: 16962466
[TBL] [Abstract][Full Text] [Related]
7. Influence of HLA mismatch on rejection after heart transplantation: a multiinstitutional study. The Cardiac Transplant Research Database Group.
Jarcho J; Naftel DC; Shroyer TW; Kirklin JK; Bourge RC; Barr ML; Pitts DG; Starling RC
J Heart Lung Transplant; 1994; 13(4):583-95; discussion 595-6. PubMed ID: 7947874
[TBL] [Abstract][Full Text] [Related]
8. Three-year survival rates for all consecutive heart-only and lung-only transplants performed in Eurotransplant, 1997-1999.
Smits JM; Vanhaecke J; Haverich A; de Vries E; Smith M; Rutgrink E; Ramsoebhag A; Hop A; Persijn G; Laufer G
Clin Transpl; 2003; ():89-100. PubMed ID: 15387100
[TBL] [Abstract][Full Text] [Related]
9. Rejection in heart transplantation strongly correlates with HLA-DR antigen mismatch.
Sheldon S; Hasleton PS; Yonan NA; Rhaman AN; Deiraniya AK; Campbell CS; Brooks NH; Dyer PA
Transplantation; 1994 Sep; 58(6):719-22. PubMed ID: 7940693
[TBL] [Abstract][Full Text] [Related]
10. HLA-DR incompatibility predicts heart transplant rejection independent of immunosuppressive prophylaxis.
Costanzo-Nordin MR; Fisher SG; O'Sullivan EJ; Johnson M; Heroux A; Kao W; Mullen GM; Radvany R; Robinson J
J Heart Lung Transplant; 1993; 12(5):779-89. PubMed ID: 8241215
[TBL] [Abstract][Full Text] [Related]
11. Cardiac allograft vasculopathy: relationship with acute cellular rejection and histocompatibility.
Costanzo-Nordin MR
J Heart Lung Transplant; 1992; 11(3 Pt 2):S90-103. PubMed ID: 1623009
[TBL] [Abstract][Full Text] [Related]
12. HLA-DR matching in organ allocation: balance between waiting time and rejection in pediatric kidney transplantation.
Vu LT; Baxter-Lowe LA; Garcia J; McEnhill M; Summers P; Hirose R; Lee M; Stock PG
Arch Surg; 2011 Jul; 146(7):824-9. PubMed ID: 21768429
[TBL] [Abstract][Full Text] [Related]
13. Influence of human leukocyte antigen matching on liver allograft survival and rejection: "the dualistic effect".
Donaldson P; Underhill J; Doherty D; Hayllar K; Calne R; Tan KC; O'Grady J; Wight D; Portmann B; Williams R
Hepatology; 1993 Jun; 17(6):1008-15. PubMed ID: 8514248
[TBL] [Abstract][Full Text] [Related]
14. Independent risk factors predicting acute graft rejection in cardiac transplant recipients treated by triple drug immunosuppression.
Laufer G; Miholic J; Laczkovics A; Wollenek G; Holzinger C; Hajek-Rosenmeier A; Wuzl G; Schreiner W; Buxbaum P; Wolner E
J Thorac Cardiovasc Surg; 1989 Dec; 98(6):1113-21. PubMed ID: 2586129
[TBL] [Abstract][Full Text] [Related]
15. HLA compatibility and organ transplant survival. Collaborative Transplant Study.
Opelz G; Wujciak T; Döhler B; Scherer S; Mytilineos J
Rev Immunogenet; 1999; 1(3):334-42. PubMed ID: 11256424
[TBL] [Abstract][Full Text] [Related]
16. The LifeLink Foundation and cadaver kidney transplantation in Tampa.
LeFor WM; Wright CE; Bowers VD; Heinrichs DF; Shires DL
Clin Transpl; 1999; ():149-58. PubMed ID: 11038633
[TBL] [Abstract][Full Text] [Related]
17. Kidney transplantation in the United States.
Cecka JM
Clin Transpl; 2008; ():1-18. PubMed ID: 19711510
[TBL] [Abstract][Full Text] [Related]
18. The effect of HLA mismatches, shared cross-reactive antigen groups, and shared HLA-DR antigens on the outcome after pediatric liver transplantation.
Sieders E; Hepkema BG; Peeters PM; TenVergert EM; de Jong KP; Porte RJ; Bijleveld CM; van den Berg AP; Lems SP; Gouw AS; Slooff MJ
Liver Transpl; 2005 Dec; 11(12):1541-9. PubMed ID: 16315307
[TBL] [Abstract][Full Text] [Related]
19. Multi-organ transplantation: is there a protective effect against acute and chronic rejection?
Pinderski LJ; Kirklin JK; McGiffin D; Brown R; Naftel DC; Young KR; Smith K; Bourge RC; Tallaj JA; Rayburn BK; Benza R; Zorn G; Leon K; Wille K; Deierhoi M; George JF
J Heart Lung Transplant; 2005 Nov; 24(11):1828-33. PubMed ID: 16297789
[TBL] [Abstract][Full Text] [Related]
20. The effect of race and ethnicity on kidney allograft outcome.
Katznelson S; Gjertson DW; Cecka JM
Clin Transpl; 1995; ():379-94. PubMed ID: 8794281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
